APO Research

APO RESEARCH · REPORT

Cortisone

Selected research

Market Analysis & Forecast

Global Cortisone Market Analysis and Forecast 2026-2032

Market perspective

The global Cortisone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cortisone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cortisone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cortisone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cortisone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Cortisone include Novartis, Merck, Pfizer, GlaxoSmithKline, AstraZeneca and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cortisone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cortisone, also provides the sales of main regions and countries. Of the upcoming market potential for Cortisone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cortisone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cortisone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cortisone sales, projected growth trends, production technology, application and end-user industry.

Cortisone Segment by Company

Novartis

Merck

Pfizer

GlaxoSmithKline

AstraZeneca

Bristol-Myers Squibb

Cortisone Segment by Type

Oral Drugs

Injectable Drugs

Cortisone Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Cortisone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cortisone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cortisone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cortisone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Cortisone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Cortisone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cortisone sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cortisone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Drugs Major Manufacturers Table 3. Injectable Drugs Major Manufacturers Table 4. Global Cortisone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacies Major Manufacturers Table 6. Retail Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Cortisone Industry Trends Table 9. Cortisone Industry Drivers Table 10. Cortisone Industry Opportunities and Challenges Table 11. Cortisone Industry Restraints Table 12. Global Cortisone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Cortisone Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Cortisone Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Cortisone Revenue Market Share by Region (2021-2026) Table 16. Global Cortisone Revenue Market Share by Region (2027-2032) Table 17. Global Cortisone Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Cortisone Sales by Region (2021-2026) & (k units) Table 19. Global Cortisone Sales by Region (2027-2032) & (k units) Table 20. Global Cortisone Sales Market Share by Region (2021-2026) Table 21. Global Cortisone Sales Market Share by Region (2027-2032) Table 22. Global Cortisone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Cortisone Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Cortisone Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Cortisone Sales Market Share by Manufacturers (2021-2026) Table 26. Global Cortisone Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Cortisone Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Cortisone Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Cortisone Manufacturers, Product Type & Application Table 30. Global Cortisone Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Cortisone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Cortisone Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cortisone Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Cortisone Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Cortisone Revenue Market Share by Type (2021-2026) Table 37. Global Cortisone Revenue Market Share by Type (2027-2032) Table 38. Global Cortisone Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Cortisone Sales by Type (2021-2026) & (k units) Table 40. Global Cortisone Sales by Type (2027-2032) & (k units) Table 41. Global Cortisone Sales Market Share by Type (2021-2026) Table 42. Global Cortisone Sales Market Share by Type (2027-2032) Table 43. Global Cortisone Price by Type (2021-2026) & (US$/unit) Table 44. Global Cortisone Price by Type (2027-2032) & (US$/unit) Table 45. Global Cortisone Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Cortisone Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Cortisone Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Cortisone Revenue Market Share by Application (2021-2026) Table 49. Global Cortisone Revenue Market Share by Application (2027-2032) Table 50. Global Cortisone Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Cortisone Sales by Application (2021-2026) & (k units) Table 52. Global Cortisone Sales by Application (2027-2032) & (k units) Table 53. Global Cortisone Sales Market Share by Application (2021-2026) Table 54. Global Cortisone Sales Market Share by Application (2027-2032) Table 55. Global Cortisone Price by Application (2021-2026) & (US$/unit) Table 56. Global Cortisone Price by Application (2027-2032) & (US$/unit) Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Cortisone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Novartis Cortisone Product Portfolio Table 61. Novartis Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Cortisone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Merck Cortisone Product Portfolio Table 66. Merck Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Cortisone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Pfizer Cortisone Product Portfolio Table 71. Pfizer Recent Development Table 72. GlaxoSmithKline Company Information Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Cortisone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Cortisone Product Portfolio Table 76. GlaxoSmithKline Recent Development Table 77. AstraZeneca Company Information Table 78. AstraZeneca Business Overview Table 79. AstraZeneca Cortisone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. AstraZeneca Cortisone Product Portfolio Table 81. AstraZeneca Recent Development Table 82. Bristol-Myers Squibb Company Information Table 83. Bristol-Myers Squibb Business Overview Table 84. Bristol-Myers Squibb Cortisone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Bristol-Myers Squibb Cortisone Product Portfolio Table 86. Bristol-Myers Squibb Recent Development Table 87. North America Cortisone Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Cortisone Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Cortisone Sales by Type (2021-2026) & (k units) Table 90. North America Cortisone Sales by Type (2027-2032) & (k units) Table 91. North America Cortisone Sales Price by Type (2021-2026) & (US$/unit) Table 92. North America Cortisone Sales Price by Type (2027-2032) & (US$/unit) Table 93. North America Cortisone Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Cortisone Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Cortisone Sales by Application (2021-2026) & (k units) Table 96. North America Cortisone Sales by Application (2027-2032) & (k units) Table 97. North America Cortisone Sales Price by Application (2021-2026) & (US$/unit) Table 98. North America Cortisone Sales Price by Application (2027-2032) & (US$/unit) Table 99. North America Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Cortisone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Cortisone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Cortisone Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 103. North America Cortisone Sales by Country (2021-2026) & (k units) Table 104. North America Cortisone Sales by Country (2027-2032) & (k units) Table 105. North America Cortisone Sales Price by Country (2021-2026) & (US$/unit) Table 106. North America Cortisone Sales Price by Country (2027-2032) & (US$/unit) Table 107. United States Cortisone Revenue (2021-2032) & (US$ Million) Table 108. Canada Cortisone Revenue (2021-2032) & (US$ Million) Table 109. Mexico Cortisone Revenue (2021-2032) & (US$ Million) Table 110. Europe Cortisone Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Cortisone Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Cortisone Sales by Type (2021-2026) & (k units) Table 113. Europe Cortisone Sales by Type (2027-2032) & (k units) Table 114. Europe Cortisone Sales Price by Type (2021-2026) & (US$/unit) Table 115. Europe Cortisone Sales Price by Type (2027-2032) & (US$/unit) Table 116. Europe Cortisone Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Cortisone Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Cortisone Sales by Application (2021-2026) & (k units) Table 119. Europe Cortisone Sales by Application (2027-2032) & (k units) Table 120. Europe Cortisone Sales Price by Application (2021-2026) & (US$/unit) Table 121. Europe Cortisone Sales Price by Application (2027-2032) & (US$/unit) Table 122. Europe Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Cortisone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Cortisone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Cortisone Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 126. Europe Cortisone Sales by Country (2021-2026) & (k units) Table 127. Europe Cortisone Sales by Country (2027-2032) & (k units) Table 128. Europe Cortisone Sales Price by Country (2021-2026) & (US$/unit) Table 129. Europe Cortisone Sales Price by Country (2027-2032) & (US$/unit) Table 130. Germany Cortisone Revenue (2021-2032) & (US$ Million) Table 131. France Cortisone Revenue (2021-2032) & (US$ Million) Table 132. U.K. Cortisone Revenue (2021-2032) & (US$ Million) Table 133. Italy Cortisone Revenue (2021-2032) & (US$ Million) Table 134. Russia Cortisone Revenue (2021-2032) & (US$ Million) Table 135. Spain Cortisone Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Cortisone Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Cortisone Revenue (2021-2032) & (US$ Million) Table 138. Sweden Cortisone Revenue (2021-2032) & (US$ Million) Table 139. Poland Cortisone Revenue (2021-2032) & (US$ Million) Table 140. China Cortisone Revenue by Type (2021-2026) & (US$ Million) Table 141. China Cortisone Revenue by Type (2027-2032) & (US$ Million) Table 142. China Cortisone Sales by Type (2021-2026) & (k units) Table 143. China Cortisone Sales by Type (2027-2032) & (k units) Table 144. China Cortisone Sales Price by Type (2021-2026) & (US$/unit) Table 145. China Cortisone Sales Price by Type (2027-2032) & (US$/unit) Table 146. China Cortisone Revenue by Application (2021-2026) & (US$ Million) Table 147. China Cortisone Revenue by Application (2027-2032) & (US$ Million) Table 148. China Cortisone Sales by Application (2021-2026) & (k units) Table 149. China Cortisone Sales by Application (2027-2032) & (k units) Table 150. China Cortisone Sales Price by Application (2021-2026) & (US$/unit) Table 151. China Cortisone Sales Price by Application (2027-2032) & (US$/unit) Table 152. Asia Cortisone Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Cortisone Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Cortisone Sales by Type (2021-2026) & (k units) Table 155. Asia Cortisone Sales by Type (2027-2032) & (k units) Table 156. Asia Cortisone Sales Price by Type (2021-2026) & (US$/unit) Table 157. Asia Cortisone Sales Price by Type (2027-2032) & (US$/unit) Table 158. Asia Cortisone Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Cortisone Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Cortisone Sales by Application (2021-2026) & (k units) Table 161. Asia Cortisone Sales by Application (2027-2032) & (k units) Table 162. Asia Cortisone Sales Price by Application (2021-2026) & (US$/unit) Table 163. Asia Cortisone Sales Price by Application (2027-2032) & (US$/unit) Table 164. Asia Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Cortisone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Cortisone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Cortisone Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. Asia Cortisone Sales by Country (2021-2026) & (k units) Table 169. Asia Cortisone Sales by Country (2027-2032) & (k units) Table 170. Asia Cortisone Sales Price by Country (2021-2026) & (US$/unit) Table 171. Asia Cortisone Sales Price by Country (2027-2032) & (US$/unit) Table 172. Japan Cortisone Revenue (2021-2032) & (US$ Million) Table 173. South Korea Cortisone Revenue (2021-2032) & (US$ Million) Table 174. India Cortisone Revenue (2021-2032) & (US$ Million) Table 175. Australia Cortisone Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Cortisone Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Cortisone Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Cortisone Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Cortisone Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Cortisone Sales by Type (2021-2026) & (k units) Table 181. SAMEA Cortisone Sales by Type (2027-2032) & (k units) Table 182. SAMEA Cortisone Sales Price by Type (2021-2026) & (US$/unit) Table 183. SAMEA Cortisone Sales Price by Type (2027-2032) & (US$/unit) Table 184. SAMEA Cortisone Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Cortisone Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Cortisone Sales by Application (2021-2026) & (k units) Table 187. SAMEA Cortisone Sales by Application (2027-2032) & (k units) Table 188. SAMEA Cortisone Sales Price by Application (2021-2026) & (US$/unit) Table 189. SAMEA Cortisone Sales Price by Application (2027-2032) & (US$/unit) Table 190. SAMEA Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Cortisone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Cortisone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Cortisone Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 194. SAMEA Cortisone Sales by Country (2021-2026) & (k units) Table 195. SAMEA Cortisone Sales by Country (2027-2032) & (k units) Table 196. SAMEA Cortisone Sales Price by Country (2021-2026) & (US$/unit) Table 197. SAMEA Cortisone Sales Price by Country (2027-2032) & (US$/unit) Table 198. Brazil Cortisone Revenue (2021-2032) & (US$ Million) Table 199. Argentina Cortisone Revenue (2021-2032) & (US$ Million) Table 200. Chile Cortisone Revenue (2021-2032) & (US$ Million) Table 201. Colombia Cortisone Revenue (2021-2032) & (US$ Million) Table 202. Peru Cortisone Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Cortisone Revenue (2021-2032) & (US$ Million) Table 204. Israel Cortisone Revenue (2021-2032) & (US$ Million) Table 205. UAE Cortisone Revenue (2021-2032) & (US$ Million) Table 206. Turkey Cortisone Revenue (2021-2032) & (US$ Million) Table 207. Iran Cortisone Revenue (2021-2032) & (US$ Million) Table 208. Egypt Cortisone Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Cortisone Distributors List Table 212. Cortisone Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Cortisone Image Figure 2. Global Cortisone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cortisone Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Drugs Image Figure 5. Injectable Drugs Image Figure 6. Global Cortisone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cortisone Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacies Image Figure 9. Retail Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Global Cortisone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cortisone Revenue (2021-2032) & (US$ Million) Figure 13. Global Cortisone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Cortisone Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Cortisone Revenue Market Share by Region (2021-2032) Figure 16. Global Cortisone Sales (2021-2032) & (k units) Figure 17. Global Cortisone Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Cortisone Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Cortisone Sales YoY (2021-2032) & (k units) Figure 20. Europe Cortisone Sales YoY (2021-2032) & (k units) Figure 21. China Cortisone Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Cortisone Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Cortisone Sales YoY (2021-2032) & (k units) Figure 24. Global Cortisone Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Cortisone Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Cortisone Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Cortisone Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Cortisone Revenue Market Share by Type (2021-2032) Figure 30. Global Cortisone Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Cortisone Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Cortisone Sales Market Share by Type (2021-2032) Figure 33. Global Cortisone Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Cortisone Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Cortisone Revenue Market Share by Application (2021-2032) Figure 36. Global Cortisone Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Cortisone Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Cortisone Sales Market Share by Application (2021-2032) Figure 39. North America Cortisone Revenue Share by Type (2021-2032) Figure 40. North America Cortisone Sales Share by Type (2021-2032) Figure 41. North America Cortisone Revenue Share by Application (2021-2032) Figure 42. North America Cortisone Sales Share by Application (2021-2032) Figure 43. North America Cortisone Revenue Share by Country (2021-2032) Figure 44. North America Cortisone Sales Share by Country (2021-2032) Figure 45. Europe Cortisone Revenue Share by Type (2021-2032) Figure 46. Europe Cortisone Sales Share by Type (2021-2032) Figure 47. Europe Cortisone Revenue Share by Application (2021-2032) Figure 48. Europe Cortisone Sales Share by Application (2021-2032) Figure 49. Europe Cortisone Revenue Share by Country (2021-2032) Figure 50. Europe Cortisone Sales Share by Country (2021-2032) Figure 51. China Cortisone Revenue Share by Type (2021-2032) Figure 52. China Cortisone Sales Share by Type (2021-2032) Figure 53. China Cortisone Revenue Share by Application (2021-2032) Figure 54. China Cortisone Sales Share by Application (2021-2032) Figure 55. Asia Cortisone Revenue Share by Type (2021-2032) Figure 56. Asia Cortisone Sales Share by Type (2021-2032) Figure 57. Asia Cortisone Revenue Share by Application (2021-2032) Figure 58. Asia Cortisone Sales Share by Application (2021-2032) Figure 59. Asia Cortisone Revenue Share by Country (2021-2032) Figure 60. Asia Cortisone Sales Share by Country (2021-2032) Figure 61. SAMEA Cortisone Revenue Share by Type (2021-2032) Figure 62. SAMEA Cortisone Sales Share by Type (2021-2032) Figure 63. SAMEA Cortisone Revenue Share by Application (2021-2032) Figure 64. SAMEA Cortisone Sales Share by Application (2021-2032) Figure 65. SAMEA Cortisone Revenue Share by Country (2021-2032) Figure 66. SAMEA Cortisone Sales Share by Country (2021-2032) Figure 67. Cortisone Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Cortisone Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Drugs
  • Injectable Drugs
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cortisone Market by Type
  3. 1.2.1 Global Cortisone Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Drugs
  5. 1.2.3 Injectable Drugs
  6. 1.3 Cortisone Market by Application
  7. 1.3.1 Global Cortisone Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacies
  9. 1.3.3 Retail Pharmacies
  10. 1.3.4 Online Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Cortisone Market Dynamics
  1. 2.1 Cortisone Industry Trends
  2. 2.2 Cortisone Industry Drivers
  3. 2.3 Cortisone Industry Opportunities and Challenges
  4. 2.4 Cortisone Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Cortisone Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Cortisone Revenue by Region
  3. 3.2.1 Global Cortisone Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cortisone Revenue by Region (2021-2026)
  5. 3.2.3 Global Cortisone Revenue by Region (2027-2032)
  6. 3.2.4 Global Cortisone Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Cortisone Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Cortisone Sales by Region
  9. 3.4.1 Global Cortisone Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Cortisone Sales by Region (2021-2026)
  11. 3.4.3 Global Cortisone Sales by Region (2027-2032)
  12. 3.4.4 Global Cortisone Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Cortisone Revenue by Manufacturers
  2. 4.1.1 Global Cortisone Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Cortisone Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Cortisone Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cortisone Sales by Manufacturers
  6. 4.2.1 Global Cortisone Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Cortisone Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Cortisone Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Cortisone Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Cortisone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Cortisone Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Cortisone Manufacturers, Product Type & Application
  13. 4.7 Global Cortisone Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Cortisone Market CR5 and HHI
  16. 4.8.2 2025 Cortisone Tier 1, Tier 2, and Tier 3
5 Cortisone Market by Type
  1. 5.1 Global Cortisone Revenue by Type
  2. 5.1.1 Global Cortisone Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Cortisone Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Cortisone Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Cortisone Sales by Type
  6. 5.2.1 Global Cortisone Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cortisone Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Cortisone Sales Market Share by Type (2021-2032)
  9. 5.3 Global Cortisone Price by Type
6 Cortisone Market by Application
  1. 6.1 Global Cortisone Revenue by Application
  2. 6.1.1 Global Cortisone Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Cortisone Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Cortisone Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Cortisone Sales by Application
  6. 6.2.1 Global Cortisone Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Cortisone Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Cortisone Sales Market Share by Application (2021-2032)
  9. 6.3 Global Cortisone Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Cortisone Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Cortisone Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Cortisone Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Cortisone Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Cortisone Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Bristol-Myers Squibb
  32. 7.6.1 Bristol-Myers Squibb Company Information
  33. 7.6.2 Bristol-Myers Squibb Business Overview
  34. 7.6.3 Bristol-Myers Squibb Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bristol-Myers Squibb Cortisone Product Portfolio
  36. 7.6.5 Bristol-Myers Squibb Recent Developments
8 North America
  1. 8.1 North America Cortisone Market Size by Type
  2. 8.1.1 North America Cortisone Revenue by Type (2021-2032)
  3. 8.1.2 North America Cortisone Sales by Type (2021-2032)
  4. 8.1.3 North America Cortisone Price by Type (2021-2032)
  5. 8.2 North America Cortisone Market Size by Application
  6. 8.2.1 North America Cortisone Revenue by Application (2021-2032)
  7. 8.2.2 North America Cortisone Sales by Application (2021-2032)
  8. 8.2.3 North America Cortisone Price by Application (2021-2032)
  9. 8.3 North America Cortisone Market Size by Country
  10. 8.3.1 North America Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Cortisone Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Cortisone Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Cortisone Market Size by Type
  2. 9.1.1 Europe Cortisone Revenue by Type (2021-2032)
  3. 9.1.2 Europe Cortisone Sales by Type (2021-2032)
  4. 9.1.3 Europe Cortisone Price by Type (2021-2032)
  5. 9.2 Europe Cortisone Market Size by Application
  6. 9.2.1 Europe Cortisone Revenue by Application (2021-2032)
  7. 9.2.2 Europe Cortisone Sales by Application (2021-2032)
  8. 9.2.3 Europe Cortisone Price by Application (2021-2032)
  9. 9.3 Europe Cortisone Market Size by Country
  10. 9.3.1 Europe Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Cortisone Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Cortisone Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Cortisone Market Size by Type
  2. 10.1.1 China Cortisone Revenue by Type (2021-2032)
  3. 10.1.2 China Cortisone Sales by Type (2021-2032)
  4. 10.1.3 China Cortisone Price by Type (2021-2032)
  5. 10.2 China Cortisone Market Size by Application
  6. 10.2.1 China Cortisone Revenue by Application (2021-2032)
  7. 10.2.2 China Cortisone Sales by Application (2021-2032)
  8. 10.2.3 China Cortisone Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cortisone Market Size by Type
  2. 11.1.1 Asia Cortisone Revenue by Type (2021-2032)
  3. 11.1.2 Asia Cortisone Sales by Type (2021-2032)
  4. 11.1.3 Asia Cortisone Price by Type (2021-2032)
  5. 11.2 Asia Cortisone Market Size by Application
  6. 11.2.1 Asia Cortisone Revenue by Application (2021-2032)
  7. 11.2.2 Asia Cortisone Sales by Application (2021-2032)
  8. 11.2.3 Asia Cortisone Price by Application (2021-2032)
  9. 11.3 Asia Cortisone Market Size by Country
  10. 11.3.1 Asia Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Cortisone Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Cortisone Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cortisone Market Size by Type
  2. 12.1.1 SAMEA Cortisone Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Cortisone Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Cortisone Price by Type (2021-2032)
  5. 12.2 SAMEA Cortisone Market Size by Application
  6. 12.2.1 SAMEA Cortisone Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Cortisone Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Cortisone Price by Application (2021-2032)
  9. 12.3 SAMEA Cortisone Market Size by Country
  10. 12.3.1 SAMEA Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Cortisone Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Cortisone Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Cortisone Value Chain Analysis
  2. 13.1.1 Cortisone Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Cortisone Production Mode & Process
  6. 13.2 Cortisone Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Cortisone Distributors
  9. 13.2.3 Cortisone Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research